Aurobindo Pharma USA Inc.
FDA inspection history in East Windsor, New Jersey, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at East Windsor, New Jersey.
Cited most
Across all Aurobindo Pharma USA observations on file
- FDCA 582(b)(4)1
- FDCA 582(b)(4)(B)(ii)(I)1
The complete Aurobindo Pharma USA file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
East Windsor, New Jersey
One Form 483 · 2024 · 2 observations
Latest: Form 483, May 15, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-05-15 | 483 Form 483 | East Windsor, New Jersey | 2 | $99 |
Investigators on these documents
FEI number 3008460374 · most recent document May 15, 2024
About Aurobindo Pharma USA Inc.
How many FDA Form 483s has Aurobindo Pharma USA Inc. received?
FDA Intel has 1 Form 483 on file for Aurobindo Pharma USA Inc.; the most recent is dated May 15, 2024.
When was Aurobindo Pharma USA Inc. last inspected by FDA?
The most recent FDA inspection document on file for Aurobindo Pharma USA Inc. is a Form 483 dated May 15, 2024, for the site in East Windsor, New Jersey.
What did FDA cite at Aurobindo Pharma USA Inc.?
The regulations cited most in the observations on file for Aurobindo Pharma USA Inc. are FDCA 582(b)(4), 1 time; FDCA 582(b)(4)(B)(ii)(I), 1 time.